These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 13130079)

  • 1. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
    Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
    Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
    Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice.
    Hassan AB; Howell JA
    Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoma-specific alterations of protein kinase C isozyme expression in Apc(MIN) mice.
    Klein IK; Ritland SR; Burgart LJ; Ziesmer SC; Roche PC; Gendler SJ; Karnes WE
    Cancer Res; 2000 Apr; 60(8):2077-80. PubMed ID: 10786662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis.
    Hao X; Frayling IM; Willcocks TC; Han W; Tomlinson IP; Pignatelli MN; Pretlow TP; Talbot IC
    Virchows Arch; 2002 Apr; 440(4):362-6. PubMed ID: 11956815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.
    Reichling T; Goss KH; Carson DJ; Holdcraft RW; Ley-Ebert C; Witte D; Aronow BJ; Groden J
    Cancer Res; 2005 Jan; 65(1):166-76. PubMed ID: 15665292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice.
    Kongkanuntn R; Bubb VJ; Sansom OJ; Wyllie AH; Harrison DJ; Clarke AR
    Oncogene; 1999 Dec; 18(51):7219-25. PubMed ID: 10602475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
    Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
    Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApcMin/+ mouse model of colon cancer: gene expression profiling in tumors.
    Leclerc D; Deng L; Trasler J; Rozen R
    J Cell Biochem; 2004 Dec; 93(6):1242-54. PubMed ID: 15486983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.
    Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M
    Oncogene; 2004 Feb; 23(5):1166-76. PubMed ID: 14647414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of adenomatous polyposis coli (APC) in tumorigenesis of human oral squamous cell carcinoma.
    Tsuchiya R; Yamamoto G; Nagoshi Y; Aida T; Irie T; Tachikawa T
    Oral Oncol; 2004 Oct; 40(9):932-40. PubMed ID: 15380172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
    Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
    Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epigenetic changes in the APC gene in sporadic colorectal carcinoma with synchronous adenoma.
    Kim JC; Koo KH; Roh SA; Cho YK; Kim HC; Yu CS; Kim HJ; Kim JS; Cho MK
    Int J Colorectal Dis; 2003 May; 18(3):203-9. PubMed ID: 12673484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome profile of human colorectal adenomas.
    Sabates-Bellver J; Van der Flier LG; de Palo M; Cattaneo E; Maake C; Rehrauer H; Laczko E; Kurowski MA; Bujnicki JM; Menigatti M; Luz J; Ranalli TV; Gomes V; Pastorelli A; Faggiani R; Anti M; Jiricny J; Clevers H; Marra G
    Mol Cancer Res; 2007 Dec; 5(12):1263-75. PubMed ID: 18171984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.